ZnT8 Exerts Anti-apoptosis of Kidney Tubular Epithelial Cell in Diabetic Kidney Disease Through TNFAIP3-NF-κB Signal Pathways

January 1, 2022
Biol Trace Elem Res
https://pubmed.ncbi.nlm.nih.gov/35871203

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/35871203

Research summary

This study investigates the role of zinc transporter 8 (ZnT8) in protecting renal tubular epithelial cells from apoptosis in diabetic kidney disease (DKD). Using ZnT8 Knockout (ZnT8-KO) mice and STZ-induced diabetic models, the researchers demonstrated that ZnT8 deficiency exacerbates renal injury, increases apoptosis, and elevates proinflammatory cytokine levels. In vitro, overexpression of ZnT8 in NRK-52E cells reduced high glucose-induced apoptosis and inflammation via upregulation of TNFAIP3 and suppression of the NF-κB pathway.

Key outcome of the study

ZnT8 plays a protective role in DKD by inhibiting apoptosis and inflammation in renal tubular epithelial cells through the TNFAIP3-NF-κB signaling pathway. Its deficiency leads to aggravated renal injury, highlighting its potential as a therapeutic target.

Mouse model

ZnT8 Knockout (ZnT8-KO) mice and STZ-induced diabetic mouse models, utilized to assess the impact of ZnT8 deficiency on renal tubular epithelial cell apoptosis and inflammation in DKD.

TARGET:
SLC30A8
ZnT8

Keywords

Diabetic kidney disease, Renal tubular epithelial cells, Apoptosis, Inflammation, Zinc transporter 8

Technical specifications

Knockout mouse model, STZ-induced diabetes, Gene overexpression, NF-κB pathway analysis

Related products

Catalogue product

No items found.

Customized product

Tissue-specific KO mouse

Use tissue- or cell-specific conditional Knockout mouse models to bypass embryonic lethality, compensatory mechanisms, complex phenotypes, etc.